Product Description
alphaKlothoLR is a patented, long-release version of the recombinant Klotho protein, which contains specific amino acid sequences, linkers, and an albumin binding group that allows for a sustained delivery of Klotho with cellular activity up to 19 days.
Follistatin (FLGR242), is a novel fragmented, modified version of Follistatin-344 (FST-344) that does not bind to the protein activin. Activin is responsible for the negative effects of myostatin inhibition such as unwanted cellular growth in laboratory models. It also contains a patented albumin binder.
For in vitro research use only.
Peptide Information
| Property | Klotho MAB | Follistatin (FLGR242) |
| Peptide Type | α-Klotho protein (1012 amino acids) + albumin binding construct: GGSGGSGGSGGRLIEDICLPRWGCLWEDD | Follistatin-Albumin Binding Construct |
| Molecular Weight | ~133-135 kDa (full construct with albumin binder) | ~40 kDa |
| Albumin Binding Affinity (Kd) | <20 nM | <20 nM |
| Synonyms | α-Klotho-albumin binding construct, Modified Klotho with glycine-serine linker | Modified Follistatin-344, FST-Albumin Construct, Extended Activity Follistatin |
Lyophilized Peptides:
These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. We do not use any fillers in this process.
Product Usage:
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.
